Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GLR5 pseudogene 2 (GLRX5P2) is a processed pseudogene located in the human genome; it is related to the GLRX5 (Glutaredoxin 5) gene but does not produce a functional protein[1][2][4]. Like many pseudogenes, it may be transcribed as RNA, which in rare cases can have regulatory effects on other genes (such as acting as a miRNA decoy or producing antisense RNA), but there is currently no specific evidence for functional activity in the case of GLRX5P2[3][6]. Pseudogenes frequently complicate genetic analyses due to sequence similarities with functional genes, but are generally not included as drug targets or biomarkers for disease[6]. It should not be classified as a typical molecular target (e.g., receptor, enzyme, transporter) since pseudogenes do not code for functional proteins and are usually not involved in drug interactions or direct cellular signaling pathways[2][6]. There is no evidence for direct involvement of GLRX5P2 in pathophysiological mechanisms or druggable disease roles[1][2][4][6].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GLR5 pseudogene 2 (GLRX5P2).